AXIM (AXIM Biotechnologies) EPS (Diluted): $0.00 (TTM As of Jun. 2025)

What is AXIM Biotechnologies EPS (Diluted)?

AXIM Biotechnologies AXIM EPS (Diluted) is $0.00 as of Jun. 2025. The stock has 7 warning signs investors should review.

AXIM Biotechnologies's Earnings per Share (Diluted) for the three months ended in Jun. 2025 was $0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2025 was $0.00.

AXIM Biotechnologies's EPS (Basic) for the three months ended in Jun. 2025 was $0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2025 was $0.00.

AXIM Biotechnologies's EPS without NRI for the three months ended in Jun. 2025 was $0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2025 was $-0.00.

During the past 3 years, the average EPS without NRIGrowth Rate was 49.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was 32.30% per year. During the past 10 years, the average EPS without NRI Growth Rate was 17.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, AXIM Biotechnologies's highest 3-Year average EPS without NRI Growth Rate was 49.70% per year. The lowest was -300.00% per year. And the median was 18.90% per year.

AXIM Biotechnologies (OTCPK:AXIM) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

AXIM Biotechnologies EPS (Diluted) Related Terms

AXIM Biotechnologies EPS (Diluted) Historical Data

* Premium members only.

The historical data trend for AXIM Biotechnologies's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AXIM Biotechnologies EPS (Diluted) Chart

AXIM Biotechnologies Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Diluted)

Get a 7-Day Free Trial

-0.06

-0.12

-0.04

-0.03

-0.01

AXIM Biotechnologies Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24	Mar25	Jun25
EPS (Diluted)	Get a 7-Day Free Trial															-0.00	-0.01	0.00	-0.00	0.00

AXIM vs HEPA, SCNI, BZYR: EPS (Diluted) Comparison

For the Biotechnology subindustry, AXIM Biotechnologies's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AXIM Biotechnologies PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AXIM Biotechnologies's PE Ratio distribution charts can be found below:

* The bar in red indicates where AXIM Biotechnologies's PE Ratio falls into.

Save Embed

AXIM Biotechnologies EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

AXIM Biotechnologies's Diluted EPS for the fiscal year that ended in Dec. 2024 is calculated as

Diluted EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-3.52	-	0)	/	318.895
	=	-0.01

AXIM Biotechnologies's Diluted EPS for the quarter that ended in Jun. 2025 is calculated as

Diluted EPS (Q: Jun. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(0.37	-	0)	/	332.957
	=	0.00

EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00

Frequently Asked Questions Learn more about EPS (Diluted) →

What does a EPS (Diluted) of $0.00 mean?

AXIM Biotechnologies (AXIM) has a EPS (Diluted) of $0.00 as of Jun. 2025. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on AXIM Biotechnologies and its competitors.

Is AXIM Biotechnologies' EPS (Diluted) too high?

AXIM Biotechnologies' current EPS (Diluted) is $0.00.

How does AXIM Biotechnologies' EPS (Diluted) compare to HEPA and SCNI?

AXIM Biotechnologies' EPS (Diluted) of $0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EPS (Diluted) for a Biotechnology company?

A good EPS (Diluted) depends on the Biotechnology industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EPS (Diluted) mean?

A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on AXIM Biotechnologies and its competitors. AXIM Biotechnologies's current EPS (Diluted) is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is AXIM Biotechnologies stock overvalued right now?

AXIM Biotechnologies (AXIM) has a current EPS (Diluted) of $0.00. The current EPS (Diluted) is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EPS (Diluted) calculated?

EPS (Diluted) is calculated from a company's financial statements. For AXIM Biotechnologies (AXIM), the current EPS (Diluted) is $0.00 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AXIM Biotechnologies Business Description

Industry Healthcare Biotechnology

Comparable Companies HEPA SCNI BZYR SLXN CLSDQ ZVSA ADAPY BPTH PKTX VRAX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Address 6048 Cornerstone Court West, Suite E1, San Diego, CA, USA, 92121

Website https://www.aximbiotech.com

AXIM Biotechnologies Inc is a integrated research and development company and developer of diagnostic healthcare solutions serving to enhance the health of people. The company focuses on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease through rapid diagnostic tests. Additionally, The company owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells.